Literature DB >> 16873829

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.

Samantha L Bowker, Sumit R Majumdar, Paul Veugelers, Jeffrey A Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16873829     DOI： 10.2337/dc06-0997

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  60 in total

1.  Metformin interacts with AMPK through binding to γ subunit.

Authors:  Yaya Zhang; Yongjun Wang; Chuanen Bao; Yingyi Xu; Huili Shen; Junjie Chen; Jianghua Yan; Yuqiang Chen
Journal:  Mol Cell Biochem       Date:  2012-05-30       Impact factor: 3.396

2.  Risk of cancer in a large cohort of U.S. veterans with diabetes.

Authors:  Elizabeth A Atchison; Gloria Gridley; J Daniel Carreon; Michael F Leitzmann; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

3.  Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.

Authors:  Adem Kalender; Anand Selvaraj; So Young Kim; Pawan Gulati; Sophie Brûlé; Benoit Viollet; Bruce E Kemp; Nabeel Bardeesy; Patrick Dennis; John J Schlager; André Marette; Sara C Kozma; George Thomas
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

Review 4.  Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

Authors:  Sara Gandini; Matteo Puntoni; Brandy M Heckman-Stoddard; Barbara K Dunn; Leslie Ford; Andrea DeCensi; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-01

5.  Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway.

Authors:  Aisha Fasih; Hosam A Elbaz; Maik Hüttemann; Andre A Konski; Steven P Zielske
Journal:  Radiat Res       Date:  2014-06-07       Impact factor: 2.841

Review 6.  Metabolic targets for potential prostate cancer therapeutics.

Authors:  Jeffrey Twum-Ampofo; De-Xue Fu; Antonino Passaniti; Arif Hussain; M Minhaj Siddiqui
Journal:  Curr Opin Oncol       Date:  2016-05       Impact factor: 3.645

7.  Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle.

Authors:  S M Hadad; D G Hardie; V Appleyard; A M Thompson
Journal:  Clin Transl Oncol       Date:  2013-12-12       Impact factor: 3.405

Review 8.  Effects of sulfonylureas on tumor growth: a review of the literature.

Authors:  Giulia Pasello; Loredana Urso; Pierfranco Conte; Adolfo Favaretto
Journal:  Oncologist       Date:  2013-09-16

Review 9.  Diabetes and cancer: Associations, mechanisms, and implications for medical practice.

Authors:  Chun-Xiao Xu; Hong-Hong Zhu; Yi-Min Zhu
Journal:  World J Diabetes       Date:  2014-06-15

10.  Histological evaluation of AMPK signalling in primary breast cancer.

Authors:  Sirwan M Hadad; Lee Baker; Philip R Quinlan; Katherine E Robertson; Susan E Bray; George Thomson; David Kellock; Lee B Jordan; Colin A Purdie; David G Hardie; Stewart Fleming; Alastair M Thompson
Journal:  BMC Cancer       Date:  2009-09-01       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.